longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BTBP

600161

12.100.58% ( +0.07 )
Delay Closed: Sep 17, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 31.60, within the reasonable range, cheaper than 47.38% of the time in the past 3 years, and the industry ranks 15/85, the industry Median 11.73.

31.6xP/E
¥12.10Stock price
¥0.38Earnings per share
31.6xP/E
Stock price¥12.10Earnings per share¥0.38

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
30.93x
Typical range
25.75x–40.71x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.73x
03978117156

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.73x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
603087SHGan & Lee
35.93x24.52%¥41.31B
002252SZShanghai RAAS
26.73x16.67%¥32.30B
300896SZIMEIK
24.54x2.02%¥26.87B
600161SHBTBP
31.60x6.67%¥23.93B
002007SZHUALAN BIOLOGICAL
28.81x4.14%¥23.28B
301301SZYili Chuanning Bio
30.03x20.59%¥17.77B
000403SZPLBIO
35.17x213.64%¥9.42B
300406SZBSBE
29.39x121.88%¥6.61B
300841SZKanghua Biological
26.49x22.92%¥6.53B
002880SZWEIGUANG BIOLOGICAL
25.66x20.82%¥4.70B
603739SHVland Biotech
37.99x25.00%¥3.10B
300653SZZHBIO
38.35x20.65%¥2.67B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.